http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017516817-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5386 |
| filingDate | 2015-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2017516817-A |
| titleOfInvention | Amide derivatives of 1-oxa-4,9-diazaspiroundecane compounds having various activities against pain |
| abstract | The present invention relates to compounds having dual pharmacological activity for both sigma (σ) receptors and μ-opioid receptors, more specifically diazaspiroundecane compounds having this pharmacological activity, It relates to a process for the preparation of such compounds, pharmaceutical compositions containing them and their use in therapy, in particular for the treatment of pain. [Chemical 1] Where Y is [Chemical formula 2] And n is 1 or 2; q is 1, 2, 3, 4, 5 or 6; X is a bond, —C (O) O—, —C (O) NR 8 —, —C (O) —, —O— or —C (R 4 R 4 ′ ) —; R 1 is C (O) R 5 or S (O) 2 R 5 . |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017535566-A |
| priorityDate | 2014-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 388.